Skip to main content

Table 2 Peri-interventional anticoagulation

From: Pulsed electron avalanche knife (PEAK) PlasmaBlade™ in pacemaker and defibrillator procedures

Anticoagulation n (%)
VKAa 87 (30.9)
NOAC 15 (5.3)
 Rivaroxaban 8 (2.8)
 Edoxaban 2 (0.7)
 Apixaban 15 (5.3)
 Dabigatran 0 (0)
DAPT 55 (19.5)
Triple therapy 6 (2.1)
  1. VKA vitamin K antagonist, DAPT dual antiplatelet therapy, NOAC novel oral anticoagulant
  2. aMean INR of patients on VKA at the time of the procedure was 1.51 ± 0.37